85 related articles for article (PubMed ID: 9671387)
1. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression.
Frizelle SP; Grim J; Zhou J; Gupta P; Curiel DT; Geradts J; Kratzke RA
Oncogene; 1998 Jun; 16(24):3087-95. PubMed ID: 9671387
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus.
Frizelle SP; Rubins JB; Zhou JX; Curiel DT; Kratzke RA
Cancer Gene Ther; 2000 Nov; 7(11):1421-5. PubMed ID: 11129284
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of both mesothelioma cell growth and Cdk4 activity following treatment with a TATp16INK4a peptide.
Frizelle SP; Kratzke MG; Carreon RR; Engel SC; Youngquist L; Klein MA; Fourre L; Shekels LL; Kratzke RA
Anticancer Res; 2008; 28(1A):1-7. PubMed ID: 18383817
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
5. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
Duan J; Chen Z; Liu P; Zhang Z; Tong T
Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
[TBL] [Abstract][Full Text] [Related]
6. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.
Craig C; Kim M; Ohri E; Wersto R; Katayose D; Li Z; Choi YH; Mudahar B; Srivastava S; Seth P; Cowan K
Oncogene; 1998 Jan; 16(2):265-72. PubMed ID: 9464545
[TBL] [Abstract][Full Text] [Related]
7. A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells.
Yang CT; You L; Lin YC; Lin CL; Mccormick F; Jablons DM
Anticancer Res; 2003; 23(1A):33-8. PubMed ID: 12680192
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line.
Lee JH; Lee CT; Yoo CG; Hong YK; Kim CM; Han SK; Shim YS; Carbone DP; Kim YW
Anticancer Res; 1998; 18(5A):3257-61. PubMed ID: 9858892
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.
Noonan DM; Severino A; Morini M; Tritarelli A; Manente L; D'Agnano I; Starace G; Baldi A; Lombardi D; Albini A; Felsani A; Paggi MG
J Cell Physiol; 2005 Mar; 202(3):922-8. PubMed ID: 15389561
[TBL] [Abstract][Full Text] [Related]
10. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein.
Kim M; Katayose Y; Rojanala L; Shah S; Sgagias M; Jang L; Jung YJ; Lee SH; Hwang SG; Cowan KH
Cell Death Differ; 2000 Aug; 7(8):706-11. PubMed ID: 10918444
[TBL] [Abstract][Full Text] [Related]
12. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
13. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
Grimison B; Langan TA; Sclafani RA
Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
[TBL] [Abstract][Full Text] [Related]
14. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
Rocco JW; Li D; Liggett WH; Duan L; Saunders JK; Sidransky D; O'Malley BW
Clin Cancer Res; 1998 Jul; 4(7):1697-704. PubMed ID: 9676844
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer.
Calbó J; Marotta M; Cascalló M; Roig JM; Gelpí JL; Fueyo J; Mazo A
Cancer Gene Ther; 2001 Oct; 8(10):740-50. PubMed ID: 11687897
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner.
Kawabe S; Roth JA; Wilson DR; Meyn RE
Oncogene; 2000 Nov; 19(47):5359-66. PubMed ID: 11103937
[TBL] [Abstract][Full Text] [Related]
19. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
20. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
